Vaccination

Investors pan for gold in rush for coronavirus vaccine

With the race on to find a coronavirus vaccine, the biotech sector—from an investor's point of view—appears to be the new gold rush, promising often giddy returns, but analysts warn that the exuberance could be exaggerated.

Diseases, Conditions, Syndromes

Worldwide lockdown hardens as Spain sees deadliest day

Tightened lockdowns across the planet saw nearly half of humanity told to stay at home in a bid to stem the spiralling coronavirus pandemic, as Spain recorded its deadliest day Tuesday and the United States braced for the ...

Diseases, Conditions, Syndromes

One third of humanity under virus lockdown

India's billion-plus population went into a three-week lockdown on Wednesday, with a third of the world now under orders to stay indoors, as US politicians agreed to spend $2 trillion to counter the economic damage of the ...

Diseases, Conditions, Syndromes

California goes on virus lockdown as Italy death toll overtakes China

California's 40 million people were under lockdown on Friday in the most drastic quarantine efforts by a US state to contain the fast-spreading coronavirus, as the global toll surged with Italy surpassing China as the country ...

Diseases, Conditions, Syndromes

Germany says virus vaccine research not for sale

Germany's foreign minister said Monday the rights to coronavirus vaccine research were not for sale, following reports Donald Trump wanted the US to buy exclusive access to a potential vaccine developed by a German biotech ...

page 3 from 6